A unique opportunity to have the world’s leading experts on ADHD in your home, as we bring to you our renowned ‘Masterclass Series’ as a webinar via Zoom. Set over 2 days, 2 hours per session, will allow you time to absorb the content from each session, plus you also will have access to the recordings on demand for up to 30 days after the event. Book now by clicking on the button above. Once booked on you will receive a link with the details of how to join Zoom.
Quick links about the event
About the days
Friday 18 September, 14.00 – 1600 UK time (09.00 – 11.00 Eastern Time), Professor Sam Cortese
Friday 25 September, 14.00 – 1600 UK time (09.00 – 11.00 Eastern Time), Professor Edmund Sonuga-Barke
Our CPD ‘Masterclass Series’ delivers advanced, evidence-based training for those working in CYP mental health, to build upon their skills, knowledge and experience. They are interactive sessions, consisting of a series of lectures delivered by world-renowned experts in the field who focus on the latest research, and the implications for best-practice.
Neuroscience provides a rational basis for the discovery of new and/or more effective treatments for ADHD. Over the last twenty years our view of ADHD neurobiology has changed considerably, with modern views emphasising its complexity and heterogeneity. This provides a potential platform for personalised therapeutic approaches. Our increasing appreciation of the plastic nature of the brain during sensitive developmental windows highlights the potential value of psychological treatments delivered early in development. There is no evidence, from blind raters, suggesting that non-pharmacological strategies for ADHD are efficacious for ADHD core symptoms. The effect sizes for ADHD drugs from short term trials are amongst the highest not only in psychiatry but also in general medicine. Network meta-analyses aimed to rank ADHD treatments according to their efficacy/safety have been published or are being conducted.
Who should attend
This day would be beneficial to those who work in a clinical or research setting with an advanced understanding of ADHD in children and young people. In particular; consultants, clinical leads, specialty doctors, nurse practitioners, educational psychologists, senior researchers, and those that work with children aﬀected with mental health issues.
“Excellent speakers, very interesting, thoroughly evidence-based and engaging” Previous delegate
- Consider whether therapeutic intervention for ADHD depends on scientific progress
- Understand the role of genetic and environmental factors in the aetiology of ADHD, and the implications for treatment
- Recognise that ADHD is a neuro-biologically heterogeneous condition, and ask whether it is important to tailor treatments to address different causal profiles in different individuals
- To be aware of, and critically appraise, available evidence synthesis on the pharmacological and non-pharmacological treatments for ADHD
- To appreciate to which extent current guidelines are based on empirical evidence
Prices and booking
Prices include a CPD certificate which is emailed after the event, plus you have the opportunity to watch the event for up to 30 days on demand. Members get a discounted rate and we hope you consider joining. Once booked on you will receive a link with the details of how to join Zoom.
- ACAMH Members: £95 (approx $125, based on exchange rate 21/07/20 via xe.com)
- Non-member: £135 (approx $170, based on exchange rate 21/07/20 via xe.com)
To book simply click on the button at the top of the screen to pay by credit or debit card. Please note that we will only issue invoices for group bookings of 10 or more for this event at a rate of £75pp.
Amongst our aims is the dissemination of information to bridge the gap between rigorous research and best practice in relation to child and adolescent mental health. One of the ways in which we do this is through our events, and we try to make these as accessible and affordable as is reasonably possible. The events we organise are not profit-making, many are subsidised through our other commercial activities, without which they would not be able to run. As a charity, any surplus that we make is invested back into the business to benefit our Members and the sector.
“Excellent Masterclass! Very informative with clear practical tips, with clear articulate speakers.” Previous delegate
About the speakers
Professor of Developmental Psychology and Neuroscience, Department of Child and Adolescent Psychiatry at the IoPPN, Kings College London
Edmund Sonuga-Barke is Professor of Developmental Psychology, Psychiatry and Neuroscience working in the Department of Child and Adolescent Psychiatry at the Institute of Psychology, Psychiatry and Neuroscience, King’s College London. He also holds a visiting chair at the University of Sussex, and is Editor in Chief of the Journal of Child Psychology and Psychiatry.
His work integrates Developmental Psychopathology and Neuroscience perspectives to employing basic developmental science approaches to study the pathogenesis of neuro-developmental and mental health conditions; their underlying genetic and environmental risks, mediating brain mechanisms and developmental outcomes. He has a particular interest in ADHD and related disorders. In 2016, Prof Sonuga-Barke was elected a Fellow of the Academy of Medical Sciences.
Samuele Cortese, is a child psychiatrist, trained in Italy, France, and in the United States. He is also Adjunct Associate Professor with the New York University (NYU). Dr Cortese’s main research interest are around the epidemiology, neurobiology and treatment of neurodevelopmental disorders, in particular ADHD, as well as on sleep disorders in children and adolescents. He has published more than 120 peer review papers (H index: 39).
Professor Cortese sits on the editorial board of several journals in the field of child mental health, including JCPP, JAACAP, Attention Deficit Hyperactivity Disorders, CNS Drugs, Journal of Child and Adolescent Psychopharmacology and Evidence Based Mental Health. Sam is a member of the European ADHD Guidelines Group and acts as the ACAMH Branch Liaison Officer.